v.wojcik
Submits third-party assay reports on material purchased directly. Based in Split.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.13%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041215 | Thymulin | WWB | WWB-2602-S2129 | Nordanalyt | 2026-Q2 | 99.27 | 3.86 | 104.9 | Buyer-sourced | 0 | PASS |
| AX-2026-043138 | BPC-157 | SSA | SSA-2601-N6863 | VendorInvestigate | 2026-Q2 | 97.99 | 4.20 | 90.1 | Buyer-sourced | 1 | FAIL |
| AX-2025-019040 | Liraglutide | ASY | ASY-{CAT}-2101 | PeptideMeter | 2025-Q4 | 99.93 | 4.35 | 103.1 | Buyer-sourced | 0 | PASS |
| AX-2025-019687 | Selank | TFC | TFC-2504-G2332 | Medutest | 2025-Q3 | 99.83 | 7.66 | 94.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020116 | Semaglutide | ERP | ERP-2508-S8293 | Janoshik | 2025-Q3 | 98.98 | 3.61 | 103.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020832 | Ipamorelin | CPC | CPC-2503-J1794 | Medutest | 2025-Q1 | 98.15 | 6.52 | 94.8 | Buyer-sourced | 0 | FAIL |
| AX-2024-004487 | Semaglutide | HYB | HYB-2407-V6435 | Janoshik | 2024-Q4 | 98.93 | 4.15 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004188 | Kisspeptin-10 | WWB | WWB-2311-T3203 | Medutest | 2024-Q2 | 99.93 | 6.19 | — | Buyer-sourced | 0 | PASS |